<DOC>
	<DOCNO>NCT01966497</DOCNO>
	<brief_summary>The main objective observational survey estimate incidence , typology , evolution patient acute myelobalstic leukemia , age 60 year old . In age group ( age 60y ) , three group patient different response rate late outcome delineate specific standard chemotherapy .</brief_summary>
	<brief_title>Observational Study Patients Older Than 60 Years With Acute Myeloblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Aged 60 year With morphologically prove diagnosis AML accord WHO 2008 classification Not previously treat AML Signed inform consent . APL WHO classification . Ph1positive AML prior Ph1positive disease AML evolve prior MPN WHO 2008 classification . Prior tumor , stable least two year , except insitu carcinoma skin carcinoma ECOG Performance Status Score &gt; 3 Positive serology HIV HTLV1 , active viralinfection HBV HBC . Severe uncontrolled infection inclusion time . Psychiatric disease history noncomplianceto medical regimen patient consider potentially unreliable . Absence Health Care Insurance</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>AML</keyword>
</DOC>